Cancer Pain and Opioid Use Disorder
Investigators support individualized approaches and compassionate care to minimize nonmedical opioid use and opioid use disorder in patients with cancer pain.
Psycho-Oncology and the Relevance of a Biopsychosocial Screening Program
Routine biopsychosocial screening of a patient with metastatic renal cell cancer at the Centro de Câncer de Brasília improved symptom management and shrunk costs for both the patient and her caregivers.
Future Directions in the Management of Non–Small Cell Lung Cancer Harboring Driver Mutations
Roy S. Herbst, MD, PhD, considers next steps in the management of patients with non–small cell lung cancer harboring genomic drivers.
Mark A. Socinski, MD, on Progression of Lung Cancer Treatment
“Opportunities to escalate therapies that work well in stage IV into what we consider a more curative setting...are exactly what we need to be looking for.” –Mark A. Socinski, MD
Is Drug Price Negotiation a Concept Whose Time Has Come?
Howard S. Hochster, MD, considers drug price negotiation in this month's Letter to the Readers.
2 Clarke Drive Cranbury, NJ 08512